BIO-MEDICAL CONSULT HOLDING ApS
CVR 32260519 · Private limited company (ApS) · Active · Low risk
BIO-MEDICAL CONSULT HOLDING ApS is a Private limited company (ApS), founded on , based in Aalborg. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 17 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 18.5m and a net result of DKK 627k. CEO: Lars Arendt-Nielsen.
Bankruptcy risk for BIO-MEDICAL CONSULT HOLDING ApS
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32260519
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (17 years)
- Address
- M.A. Schultz Vej 7
9000 Aalborg - Municipality
- Aalborg
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 152k
- Auditor
- Redmark, Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 2 of 17 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 79.2% |
| Current ratio | 393% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -27k | DKK -39k | DKK -21k |
| Net profit | DKK 627k | DKK 1.8m | DKK 1.4m |
| Equity | DKK 18.5m | DKK 17.9m | DKK 16.2m |
| Total assets | DKK 23.4m | DKK 22.4m | DKK 19.3m |
| Cash | DKK 434k | DKK 205k | – |
| Short-term debt | DKK 4.8m | DKK 4.5m | – |
| Tax owed | DKK 0 | DKK 295k | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 120 | ||
| 1 Jan 2024 – 31 Dec 2024 | 174 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 1 Jan 2022 – 31 Dec 2022 | 193 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 1 Jan 2020 – 31 Dec 2020 | 189 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 181 | ||
| 1 Jan 2018 – 31 Dec 2018 | 155 | ||
| 1 Jan 2017 – 31 Dec 2017 | 152 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 159 | ||
| 1 Jan 2014 – 31 Dec 2014 | 161 | ||
| 1 Jan 2013 – 31 Dec 2013 | 157 | ||
| 1 Jan 2012 – 31 Dec 2012 | 159 | ||
| 1 Jan 2011 – 31 Dec 2011 | 159 | ||
| 1 Jan 2010 – 31 Dec 2010 | 156 | ||
| 11 Jun 2009 – 31 Dec 2009 | 153 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lars Arendt-Nielsen | Current | |
| Owner (90%) | Lars Arendt-Nielsen | Current | |
| Auditor | REVISIONSFIRMAET DENNIS MØLLER | ||
| Auditor | REDMARK, GODKENDT REVISIONSPARTNERSELSKAB | ||
| Founder | Lars Arendt-Nielsen | Current |
The CEOs' other companies
Lars Arendt-Nielsen – 8 other companies, of which 1 bankrupt
- NOXITEST BIOMEDICAL A/S Bankrupt 20 Feb 2003
- ANESIDORA AALBORG ApS Fusioneret
- ANPARTSSELSKABET AF 1/1 2004 Opløst
- Anpartsselskab 2013 Opløst
- BIO-MEDICAL CONSULT ApS Fusioneret
- C4PAIN ApS Active
- LBN MEDICAL ApS Active
- NOXITEST INSTITUTE A/S Compulsorily dissolved
Address history (0 moves)
| M.A. Schultz Vej 7, 9000 Aalborg |
Other companies at the same address
- ANESIDORA AALBORG ApS Fusioneret
- BIO-MEDICAL CONSULT ApS Fusioneret
- C4PAIN ApS Active
Similar companies in Aalborg
- IBLI HOLDING A/S Aalborg
- BRISAN ApS Svenstrup J
- NORTHERN ATLANTIC FINANCE ApS Aalborg Øst
- E.K.C. HOLDING ApS Svenstrup J
- TIKA HOLDING A/S Aalborg
- NØVLING MASKINSTATION A/S Gistrup
- FLINDT BJERG & ARNDT NIELSEN ApS Kongerslev
- N.S. HANDEL ApS Aalborg
- ASX 3411 ApS Aalborg SØ
- BRDR. SVENDSEN HOLDING ApS Kongerslev
- LARS KRULL HOLDING A/S Aalborg
- T.Å.J. INVEST ApS Aalborg
Questions and answers about BIO-MEDICAL CONSULT HOLDING ApS
Has BIO-MEDICAL CONSULT HOLDING ApS gone bankrupt?
No, BIO-MEDICAL CONSULT HOLDING ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIO-MEDICAL CONSULT HOLDING ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of BIO-MEDICAL CONSULT HOLDING ApS?
Lars Arendt-Nielsen is the CEO of BIO-MEDICAL CONSULT HOLDING ApS.
Who is the auditor of BIO-MEDICAL CONSULT HOLDING ApS?
BIO-MEDICAL CONSULT HOLDING ApS most recently used Redmark, Godkendt Revisionspartnerselskab.
When was BIO-MEDICAL CONSULT HOLDING ApS founded?
BIO-MEDICAL CONSULT HOLDING ApS was founded on 11 June 2009.
What is the equity of BIO-MEDICAL CONSULT HOLDING ApS?
Equity was DKK 18.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.